West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
417.83
+0.03 (0.01%)
Nov 17, 2026, 10:31 AM EST - Market open
WST Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, WST stock has a consensus rating of "Strong Buy" and an average price target of $471. The average 1-year stock price forecast is 12.73% higher than the current stock price, while the lowest is $340 (-18.63%) and the highest is $500 (+19.67%).
Price Target: $471 (+12.73%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for WST stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 12 | 12 | 12 |
| Buy | 2 | 3 | 3 | 4 | 3 | 3 |
| Hold | 1 | 2 | 2 | 1 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 17 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $420 → $500 | Buy | Maintains | $420 → $500 | +19.67% | Oct 30, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $440 → $480 | Buy | Maintains | $440 → $480 | +14.88% | Oct 30, 2026 |
| UBS | UBS | Buy Maintains $435 → $495 | Buy | Maintains | $435 → $495 | +18.47% | Oct 30, 2026 |
| Citi | Citi | Buy Reiterates $412 → $494 | Buy | Reiterates | $412 → $494 | +18.23% | Oct 30, 2026 |
| Barclays | Barclays | Buy Maintains $440 → $500 | Buy | Maintains | $440 → $500 | +19.67% | Oct 30, 2026 |
Financial Forecast
Revenue This Year
3.42B
from 3.07B
Increased by 11.26%
Revenue Next Year
3.62B
from 3.42B
Increased by 5.92%
EPS This Year
9.46
from 7.29
Increased by 29.79%
EPS Next Year
10.39
from 9.46
Increased by 9.85%
EPS and Forward PE are based on non-GAAP adjusted numbers.